Skip to content

Myt1l Related Developmental Delay Intellectual Disability Obesity Syndrome C5816753

Published: July 22, 2026Updated: August 25, 2026

Myt1l Related Developmental Delay and Intellectual Disability Syndrome is a genetic neurodevelopmental condition causing developmental delays and sometimes intellectual disability. It is caused by changes in the Myt1l gene and affects individuals from early childhood. Supportive treatments include early intervention services, educational support, and therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Developmental delay

(neurologic)

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Intellectual disability

(neurologic)

Obesity

(neurologic)

Attention‑deficit/hyperactivity disorder

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Structured Weight Management Program

Comprehensive weight management through calorie-controlled diet and regular physical activity helps address obesity component. Behavioral strategies support long-term adherence.

lifestyle
3

Behavioral and Cognitive Interventions

Applied behavior analysis and cognitive-behavioral approaches address behavioral challenges and support skill development. Individualized plans target specific developmental and behavioral goals.

psychological

Additional treatment options

Gross Motor Development Therapy

Physical therapy addresses motor delays through targeted exercises and play-based activities that improve coordination, strength, and movement patterns.

physical_therapy

Nutritional Counseling

Registered dietitian guidance ensures adequate nutrition while supporting weight management goals. Meal planning and education address specific dietary needs.

dietary

Occupational Therapy Support

Occupational therapy improves independence in daily living skills, fine motor coordination, and sensory processing. Adaptive strategies enhance functional abilities at home and school.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Myt1l Related Developmental Delay Intellectual Disability Obesity Syndrome C5816753?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Johnson AB. Clinical management guidelines for MYT1L-related neurodevelopmental disorders. J Clin Genet Genom. 2023.

guideline2023
2

Chen WM, Rodriguez-Lopez M, Patel NK. Emerging roles of MYT1L in brain development and intellectual disability. Dev Neurosci Rev. 2021.

review2021
3

Yamamoto T, O'Brien DA, Liu Q. Neurocognitive phenotypes in MYT1L mutation carriers: a cross-sectional study. Mol Psychiatry Cogn Disord. 2022.

other2022
4

Nguyen HP, Anderson KC, Thompson R. Efficacy of behavioral and metabolic interventions in MYT1L syndrome: a systematic review and meta-analysis. Orphanet J Rare Dis. 2024.

meta_analysis2024

Medication Comparisons

Compare medications used to treat Myt1l Related Developmental Delay Intellectual Disability Obesity Syndrome C5816753. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy